Filing Details
- Accession Number:
- 0000899243-19-003603
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-14 16:06:58
- Reporting Period:
- 2019-02-12
- Accepted Time:
- 2019-02-14 16:06:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1527599 | Synlogic Inc. | SYBX | Pharmaceutical Preparations (2834) | 261824804 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1714565 | Francis Paul Miller | C/O Synlogic, Inc. 301 Binney Street, Suite 402 Cambridge MA 02142 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-02-12 | 3,151 | $9.75 | 53,984 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-13 | 5,849 | $9.75 | 48,135 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2018.
Billionaire Hedge Funds
